Substance / Medication

Apraclonidine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Impact of positive airway pressure therapy on intraocular pressure in obstructive sleep apnea: A systematic review.
Singh Mamta, Deokar Kunal, Dutta Siddhartha et al. · Eur J Ophthalmol · 2025
PMID: 38689462Meta-Analysis
Changes in individuals' glaucoma progression velocity after IOP-lowering therapy: A systematic review.
Naik Vihar, Ohri Simran, Fernandez Elise et al. · PLoS One · 2025
PMID: 40440265Meta-AnalysisFull text (PMC)
Multifaceted behavioral interventions to improve topical glaucoma therapy adherence in adults.
Kruoch Zanna, Amin Pathik, Shelton Erica et al. · Cochrane Database Syst Rev · 2025
PMID: 40497459Meta-AnalysisFull text (PMC)
Efficacy and Drug Interactions of Glaucoma Medications: A Systematic Review and Component Network Meta-analysis.
Hsia Yun, Wang Chi, Su Chien-Chia et al. · Ophthalmology · 2025
PMID: 40701331Meta-Analysis
Anterior chamber paracentesis for increased intraocular pressure with intravitreal injections: systematic review and meta-analysis.
Zaman Michele, Alowedi Sarah, Sharma Sanjay · Can J Ophthalmol · 2025
PMID: 40712658Meta-Analysis
Safety and Efficacy of Omidenepag Isopropyl for Elevated Intraocular Pressure: A Systematic Review and Meta-Analysis.
Sharma Sohat, Singh Rishav, Balas Michael et al. · Am J Ophthalmol · 2025
PMID: 40714057Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Apraclonidine hydrochloride (substance)
SNOMED CT
17244004
UMLS CUI
C0304657

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.